Patents by Inventor Vishwajeet PURI

Vishwajeet PURI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11433117
    Abstract: Methods and FSP27 compositions for treating and/or preventing metabolic disease and conditions associated insulin resistance, obesity, inflammation and dyslipidemia are described.
    Type: Grant
    Filed: June 14, 2018
    Date of Patent: September 6, 2022
    Assignee: Ohio University
    Inventors: Vishwajeet Puri, John Kopchick, Vishva Sharma
  • Patent number: 11426445
    Abstract: FSP27 compositions and methods for treating cancers are described.
    Type: Grant
    Filed: September 17, 2018
    Date of Patent: August 30, 2022
    Assignee: Ohio University
    Inventors: John Kopchick, Vishwajeet Puri, Vishva Sharma, Reetobrata Basu
  • Publication number: 20210275633
    Abstract: FSP27 compositions and methods for treating cardiovascular diseases are described.
    Type: Application
    Filed: July 23, 2019
    Publication date: September 9, 2021
    Applicant: Ohio University
    Inventors: Vishwajeet Puri, John J. Kopchick, Vishva Sharma, Noyan Gokce, Shakun Karki
  • Publication number: 20200222502
    Abstract: FSP27 compositions and methods for treating cancers are described.
    Type: Application
    Filed: September 17, 2018
    Publication date: July 16, 2020
    Applicant: Ohio University
    Inventors: John Kopchick, Vishwajeet Puri, Vishva Sharma, Reetobrata Basu
  • Publication number: 20200179483
    Abstract: Methods and FSP27 compositions for treating and/or preventing metabolic disease and conditions associated insulin resistance, obesity, inflammation and dyslipidemia are described.
    Type: Application
    Filed: June 14, 2018
    Publication date: June 11, 2020
    Applicant: Ohio University
    Inventors: Vishwajeet Puri, John Kopchick, Vishva Sharma
  • Patent number: 10253325
    Abstract: In some embodiments, the present invention provides a method of elevating lipid content in vegetative (non-seed) plant or algae cells, plant tissues, or whole plants by genetically modifying the plant or algae to express a lipid droplet-associated protein or polypeptide (such as fat-specific protein 27) of mammalian origin. Also provided are genetically-modified plant or algae cells, plant tissues, or whole plants with elevated cellular lipid content, expressing a lipid droplet-associated protein or polypeptide (such as fat-specific protein 27) of mammalian (e.g. human) origin.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: April 9, 2019
    Assignee: BOSTON MEDICAL CENTER CORPORATION
    Inventors: Vishwajeet Puri, Kent Chapman, Christopher James
  • Publication number: 20150329870
    Abstract: In some embodiments, the present invention provides a method of elevating lipid content in vegetative (non-seed) plant or algal cells, plant tissues, or whole plants by genetically modifying the plant or algae to express a protein or polypeptide associated with lipid metabolism (such as fat-specific protein 27) of animal origin or plant origin. Also provided are genetically-modified plant or algal cells, plant tissues, or whole plants with elevated cellular lipid content, expressing a protein or polypeptide associated with lipid metabolism (such as fat-specific protein 27) of animal (e.g. human) origin or plant origin.
    Type: Application
    Filed: December 19, 2013
    Publication date: November 19, 2015
    Inventors: Vishwajeet Puri, Kent Chapman, Christopher James, Yingqi Cai
  • Publication number: 20140173777
    Abstract: In some embodiments, the present invention provides a method of elevating lipid content in vegetative (non-seed) plant or algae cells, plant tissues, or whole plants by genetically modifying the plant or algae to express a lipid droplet-associated protein or polypeptide (such as fat-specific protein 27) of mammalian origin. Also provided are genetically-modified plant or algae cells, plant tissues, or whole plants with elevated cellular lipid content, expressing a lipid droplet-associated protein or polypeptide (such as fat-specific protein 27) of mammalian (e.g. human) origin.
    Type: Application
    Filed: March 14, 2013
    Publication date: June 19, 2014
    Applicants: UNIVERSITY OF NORTH TEXAS, BOSTON MEDICAL CENTER CORPORATION
    Inventors: Vishwajeet PURI, Kent CHAPMAN, Christopher JAMES